Source: Health Sciences Authority (SG) Revision Year: 2022 Publisher: Abbott Products Operations AG, Hegenheimermattweg 127, 4123 Allschwil, Switzerland
LIPANTHYL PENTA 145, Film-coated tablet.
| Pharmaceutical Form |
|---|
|
Film coated tablet. White, oblong, film-coated tablets engraved “145” on one side and “Fournier logo” on the other side. |
One film-coated tablet contains 145.0mg fenofibrate (nanoparticles).
Excipients with known effect: each tablet contains:
For excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fenofibrate |
Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III. |
| List of Excipients |
|---|
|
Core: Sucrose, Lactose monohydrate, Silicified microcrystalline cellulose, Crospovidone, Hypromellose, Sodium lauril sulfate, Docusate sodium, Magnesium stearate. Coating: Polyvinyl alcohol, Titanium dioxide (E171), Talc, Soybean lecithin, Xanthan gum. |
Thermoformed blister strips (clear PVC/PE/PVDC sealed with aluminium complex).
Boxes of 30 tablets.
Abbott Products Operations AG, Hegenheimermattweg 127, 4123 Allschwil, Switzerland
| Drug | Countries | |
|---|---|---|
| LIPANTHYL | Austria, Estonia, Finland, France, Hong Kong, Lithuania, Poland, Romania, Singapore, Tunisia, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
